Health-tech startup eKincare secures funding to fuel expansion

ANI | Updated: Jan 30, 2018 12:25 IST

New Delhi [India], Jan 30 (ANI): eKincare, an integrated healthcare benefits platform driven by Artificial Intelligence (AI) announced an undisclosed amount of Series A funding, which will be used to fuel their expansion drive.

eKincare's AI powered personal health assistant reads medical data from health records and various healthcare interventions, predict health risks and provide timely personalised recommendations to beat those risks.

Through its understanding and usage of technology, data science and curated services, the start-up assisted organisations to reach their optimal health and save on healthcare costs; thereby helping them become more strategic and efficient in their employee benefits spend.

Trusted by fortune 500 companies, like Optum, Unilever, Barclays and Disney among others, the Hyderabad-based health-tech startup has strategic partners in over 2000 locations across India. As India's only end-to-end integrated healthcare solution, with the ability to collect, structure and provide meaningful insights, eKincare is also adding value to insurance through quicker and efficient decision making, data-driven underwriting of risk, reduced costs, minimised fraud and errors through automation.

"We have seen a lot of interest from corporates to leverage our platform for their employees, keep track of the overall organisation's wellness metrics and maximise the ROI out of their wellness budgets. The current round of funding will be used to grow and expand our technology platform and sales team and also get more doctors onboard," said Kiran Kalakuntla, Founder and CEO, eKincare.

Amongst the top Indian startups selected by Swiss Re for its first ever global accelerator program, eKincare received a no-obligation grant of USD 15,000 to further develop its product.

The investors involved in this round include Ventureast, Endiya Partners, Eight Roads, Bitkemy Ventures, and Padma Shri BVR Mohan Reddy. (ANI)

iocl